Satellos’ ‘intriguing’ Duchenne data raise hopes ahead of key readout
From the article
Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy drug candidate is active in adults, leading analysts to predict the molecule “could re-imagine the ... therapeutic landscape” if the biotech replicates the data in children.
Continue reading on Fierce BiotechYou might also wanna read
Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)
clinicaltrials.gov·7d ago
CRISPR’s next act: the companies editing the epigenome to treat disease
go.nature.com·7d ago
AI accelerates search for motor neurone disease treatments by repurposing existing drugs
Researchers are using AI to accelerate the search for drugs to treat motor neurone disease (MND). By repurposing existing approved drugs, th
bbc.co.uk·1mo ago
La creatina no solo desarrolla músculo: un estudio revela su potencial para fortalecer la inmunoterapia contra el cáncer
Infobae·7h ago
MySuppleHub: Community Supplement Encyclopedia
mysupplehub.org·15h agoMethod to reverse cellular ageing is about to be tested in humans
nature.com·2mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.